TuneIn, the world’s leading live audio service, brings together live radio, sports, news, music, podcasts, and audiobooks from around the globe.
With more than 75 million monthly active users, TuneIn is one of the most widely used audio platforms in the world. TuneIn broadcasts over 100k owned & operated and partner radio stations.
With premier distribution across 200 platforms and connected devices including Tesla and Alexa, TuneIn empowers listeners to hear what they love wherever they are, including exclusive commercial-free stations from the minds of folks like Garth Brooks.
TuneIn Premium subscribers get additional exclusive access to commercial-free news from top networks like CNN, Fox News Radio, MS NOW, and Bloomberg, commercial-free music for every mood, as well as live college sports and motorsports.
_________________________________________________________________
TuneIn has been made aware of fraudulent activities by individuals impersonating our company. We have reported this fraudulent activity to the Federal Trade Commission (FTC), the Department of Justice, and local authorities.
When considering a position at TuneIn, keep in mind that all legitimate communications from TuneIn will come from official email addresses ending in @tunein.com, and all of our current job openings are listed on our official careers page. If you find a job listing on another site, cross-check it with our official website.
TuneIn does not require any form of payment or sensitive personal information during the recruitment process and all genuine interviews are conducted through Zoom. If you receive any suspicious communication, please do not hesitate to verify its authenticity by reaching out to us via TuneIn LinkedIn’s page.
If you have been targeted by these scammers, we encourage you to report it to the FTC at https://reportfraud.ftc.gov/, and the FBI at https://www.ic3.gov/.
Crescendo Systems Corporation is a leading developer of Documentation, Digital Dictation, Voice Processing, Transcription and Workflow Management systems for the medical, legal, law enforcement and insurance sectors.
Established in Laval, Canada in 1990 with a solid focus on providing customer rich documentation solutions, Crescendo Systems are now in use in over 15 countries in 3 languages. In North America, Crescendo provides its solutions both directly and through a network of qualified resellers. In Asia, Australia, the Middle East and Africa, Crescendo Systems are sold through resellers with an established presence in major cities.
In Europe, there are three Crescendo subsidiaries. The first was established in London, England in 2003, and now has over 500 installations. The German subsidiary located in Hamburg was started in 2010 and Paris, France was established in 2013. All three locations are expanding at a record rate in their home markets.
Hearing preventive care is virtually unknown today, while hearing impairment is among the largest incurable chronic disabilities, impacting the quality of life and livelihood for billions worldwide. It is likely you or someone you know suffers.
Soundbites is a public benefit corporation aiming to fill that gap with ACEMg®, an auditory micronutrition formula for hearing preservation developed at the University of Michigan Medical School, supported for three decades by NIH and EU medical innovation grants, available without prescription since 2019.
Since 1988, the journey from basic science discovery to real-world evidence is one of the longest-running translational research programs in auditory neuroscience.
Auditory micronutrition supports the oxidative defense and metabolic resilience of the cells that make hearing possible, designed to complement clinical care by adding daily maintenance to the tools clinicians already use, a low-cost, high-value improvement to the current standard of care that misses the early signs of hearing loss, costing consumers billions compensating for it after the fact.
Our approach is grounded in peer-reviewed research, including a 2026 real-world evidence study reporting that 75.3% of ACEMg users showed stability or improvement in otoacoustic emissions (OAE) examination scores within 6 months of daily
supplementation. 37.6% showed no decline and 37.7% showed improvement in objective cochlear function, whereas 73.2% of the untreated group showed a decline. (N=190 (Treatment n=93, Control n=97)).